These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony]. Steinbach F; Schuster F Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407 [TBL] [Abstract][Full Text] [Related]
85. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439 [TBL] [Abstract][Full Text] [Related]
86. BCG treatment of existing Ta, T1 tumours or carcinoma in situ of the bladder. Akaza H Eur Urol; 1995; 27 Suppl 1():9-12. PubMed ID: 7750530 [TBL] [Abstract][Full Text] [Related]
87. Staging with computed tomography, transrectal ultrasonography and transurethral resection of bladder tumour: comparison with final pathological stage in invasive bladder carcinoma. Yaman O; Baltaci S; Arikan N; Yilmaz E; Gögüs O Br J Urol; 1996 Aug; 78(2):197-200. PubMed ID: 8813912 [TBL] [Abstract][Full Text] [Related]
88. Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment. Jahnson S; Hosseini Aliabad A; Holmäng S; Jancke G; Liedberg F; Ljungberg B; Malmström PU; Rosell J Scand J Urol; 2016; 50(1):14-20. PubMed ID: 26382667 [TBL] [Abstract][Full Text] [Related]
89. [Carcinoma of the bladder. Retrospective study of 396 cases]. Bertoni F; Bacchini P Pathologica; 1979; 71(1015):581-600. PubMed ID: 551384 [No Abstract] [Full Text] [Related]
90. Significance of random bladder biopsies in superficial bladder cancer. May F; Treiber U; Hartung R; Schwaibold H Eur Urol; 2003 Jul; 44(1):47-50. PubMed ID: 12814674 [TBL] [Abstract][Full Text] [Related]
91. Superficial bladder cancer: part 1. Update on etiology, classification and natural history. Josephson DY; Pasin E; Stein JP Expert Rev Anticancer Ther; 2006 Dec; 6(12):1723-34. PubMed ID: 17181486 [TBL] [Abstract][Full Text] [Related]
92. [Significance of local tumor associated infiltration of mononuclear leukocytes for persistent tumor formations following transurethral resection (TUR) of bladder cancers]. Flamm J Z Urol Nephrol; 1985 Feb; 78(2):65-70. PubMed ID: 3993242 [TBL] [Abstract][Full Text] [Related]
94. Ultrasound and computed tomography in staging of bladder tumours. Gualdi GF; Di Natale G; Liberti M; Di Biasi C; Iannicelli E Eur J Radiol; 1982 Nov; 2(4):296-300. PubMed ID: 7151817 [TBL] [Abstract][Full Text] [Related]
95. Cystoscopic forceps biopsies and transurethral resection specimens in the classification of bladder tumours. Hansen RI; Højgaard K Scand J Urol Nephrol; 1982; 16(2):151-3. PubMed ID: 7123166 [No Abstract] [Full Text] [Related]
96. The value of transurethral sonography in tumours of the urinary bladder. Schickel W; Müller GW; Friebel H; Richter A Int Urol Nephrol; 1985; 17(1):23-7. PubMed ID: 3888903 [TBL] [Abstract][Full Text] [Related]
97. COMPARATIVE RESULTS OF MODERN EXAMINATION METHODS IN EARLY DIAGNOSIS OF BLADDER CANCER, DETERMINATION OF THE DEGREE OF INVASION AND SELECTION OF RADICAL TREATMENT TACTICS. Imamverdiyev S; Qasımov E; Naghıyev R Georgian Med News; 2023 Jan; (334):98-102. PubMed ID: 36864801 [TBL] [Abstract][Full Text] [Related]